STEAP4 and neoplasm: These findings establish a previously unrecognized mechanism whereby STEAP4+ myoCAF in the tumor microenvironment contribute to therapy resistance through TFE3‐regulated autophagy and HSP90/HIF1A‐mediated stemness.